Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 2/20 | 1.00 |
| ▸ | CES1 | P23141 | 2/20 | 1.00 |
| ▸ | MAPT | P10636 | 2/20 | 0.72 |
| ▸ | CA1 | P00915 | 6/20 | 0.70 |
| ▸ | CA2 | P00918 | 6/20 | 0.70 |
| ▸ | PARP10 | Q53GL7 | 2/20 | 0.67 |
| ▸ | PARP1 | P09874 | 1/20 | 0.67 |
| ▸ | PARP2 | Q9UGN5 | 1/20 | 0.67 |
| ▸ | PARP4 | Q9UKK3 | 1/20 | 0.67 |
| ▸ | PLK1 | P53350 | 1/20 | 0.61 |
| ▸ | GSK3B | P49841 | 1/20 | 0.59 |
| ▸ | MEN1 | O00255 | 1/20 | 0.59 |
| ▸ | LMNA | P02545 | 1/20 | 0.59 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.59 |
| ▸ | RAB9A | P51151 | 1/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.59 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.59 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.59 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.59 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14507040 | 1.00 | CES2 (1.00) | CES2CES1MAPTCA1CA2 | |
| SCHEMBL29548151 | 0.97 | CES2 (0.95) | CES2CES1MAPTCA1CA2 | |
| SCHEMBL8669380 | 0.93 | CES2 (0.86) | CES2CES1MAPTCA1CA2 | |
| SCHEMBL14947045 | 0.91 | CES2 (0.83) | CES2CES1MAPTCA1CA2 | |
| SCHEMBL12700321 | 0.91 | CES2 (0.83) | CES2CES1MAPTCA1CA2 | |
| SCHEMBL2156563 | 0.91 | CES2 (1.00) | CES2CES1MAPTCA1CA2 | |
| Bromide SCHEMBL981452 | 0.89 | CES2 (0.96) | CES2CES1MAPTCA1CA2 | |
| SCHEMBL9125486 | 0.89 | CES2 (0.79) | CES2CES1MAPTCA1CA2 | |
| Hydrochloric Acid SCHEMBL905770 | 0.89 | CES2 (0.96) | CES2CES1MAPTCA1CA2 | |
| SCHEMBL2320546 | 0.88 | CES2 (0.78) | CES2CES1MAPTCA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 774 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250000813-A1 | OROMUCOSAL NANOFIBER CARRIERS FOR THERAPEUTIC TREATMENT | INSTAR TECHNOLOGIES A.S. (CZ) | 2025-01-02 | — | — | US | claimed |
| US-12180183-B2 | Water-soluble fluorescent probe and nanoparticals with aggregation-induced emission effect for ovarian cancer and preparation method and use thereof | HUNAN TARGETING DETECTION TECHNOLOGY CO., LTD. (CN) | 2024-12-31 | — | — | US | claimed |
| CN-119143591-A | Benzyl benzoyl or fluoro alkane substituted phenol compound and synthetic method and application thereof | 河北中医药大学 | 2024-12-17 | — | — | CN | claimed |
| US-12012385-B1 | 4,5-bis(4-methoxyphenyl)-1-hexyl-2-phenyl-1H-imidazole as an antimicrobial compound | King Faisal University (SA) | 2024-06-18 | — | — | US | claimed |
| US-20240168374-A1 | PHOTORESIST COMPOSITION | TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY, LTD. (TW) | 2024-05-23 | — | — | US | claimed |
| US-11964946-B1 | 4,5-bis(4-methoxyphenyl)-1-hexyl-2-(4-nitrophenyl)-1H-imidazole as an antimicrobial compound | King Faisal University (SA) | 2024-04-23 | — | — | US | claimed |
| EP-3976878-B1 | METHODS OF MAKING A DEFLECTION MEMBER | PROCTER & GAMBLE (US) | 2023-07-05 | — | — | EP | claimed |
| US-11590694-B2 | Methods of making a deflection member | THE PROCTER & GAMBLE COMPANY (US) | 2023-02-28 | — | — | US | claimed |
| EP-3976878-A1 | METHODS OF MAKING A DEFLECTION MEMBER | The Procter & Gamble Company (US) | 2022-04-06 | — | — | EP | claimed |
| US-8993650-B2 | Mixable and color tone freely reproducible dental coloring material composition, and set and method thereof | KABUSHIKI KAISHA SHOFU (JP) | 2015-03-31 | — | — | US | claimed |
| US-7973034-B2 | Ameliorating toxic effects of such as cancer therapy drugs or addictive drug overdose | ST. JUDE CHILDREN'S RESEARCH HOSPITAL (US) | 2011-07-05 | — | — | US | claimed |
| US-6328793-B1 | FOR USE IN INK JET PRINTING PROCESSES, INCLUDING PIEZOELECTRIC INK JET PRINTING, ACOUSTIC INK JET PRINTING | XEROX CORPORATION | 2001-12-11 | — | — | US | claimed |
| US-5153236-A | Comprising an N-aryl-alpha-amino acid and a photosensitizer such as a thixoanthone, isoalloxazine or coumarine; high sensitivity to UV and visible light; storage stability; photoresists; relief images | HITACHI CHEMICAL CO., LTD. (JP) | 1992-10-06 | — | — | US | claimed |
| EP-0043480-B1 | PROCESS FOR FORMING METALLIC IMAGES | Hitachi, Ltd. (JP) | 1985-04-03 | — | — | EP | claimed |
| US-4347304-A | PHOTOSENSITIZATION WITH DISILANES OR ORGANIC COMPOUNDS HAVING COUPLED GERMANIUM OR TIN MOLECULES; PHOTORESISTS; POSITIVES; PLATING | HITACHI, LTD. (JP) | 1982-08-31 | — | — | US | claimed |
| EP-0043480-A2 | Process for forming metallic images | Hitachi, Ltd. (JP) | 1982-01-13 | — | — | EP | claimed |
| US-4087463-A | COBALT CARBONYL CATALYST | MONSANTO COMPANY (US) | 1978-05-02 | — | — | US | claimed |
| JP-4244923-A | — | — | None | — | — | JP | disclosed |
| US-3948894-A | ANTIINFLAMMATORY | ELI LILLY AND COMPANY (US) | 1976-04-06 | — | — | US | disclosed |
| US-3941811-A | Oxidation process | ROUSSEL-UCLAF (FR) | 1976-03-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12180183-B2 | Water-soluble fluorescent probe and nanoparticals with aggregation-induced emission effect for ovarian cancer and preparation method and use thereof | PHOSPHO1, LPAR1, LPAR3 | CES2 4835/4885CES1 3127/4885MAPT 2541/4885 |
| US-12012385-B1 | 4,5-bis(4-methoxyphenyl)-1-hexyl-2-phenyl-1H-imidazole as an antimicrobial compound | TLR4, CASP4, IL4 | CES2 3711/4885CES1 3926/4885MAPT 1865/4885 |
| US-11964946-B1 | 4,5-bis(4-methoxyphenyl)-1-hexyl-2-(4-nitrophenyl)-1H-imidazole as an antimicrobial compound | TLR4, CASP4, IL4 | CES2 3587/4885CES1 3617/4885MAPT 2407/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.